O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.98B
AUM Growth
-$187M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
122
New
Increased
Reduced
Closed

Top Buys

1 +$81.1M
2 +$42.1M
3 +$31.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.4M
5
CTMX icon
CytomX Therapeutics
CTMX
+$19.2M

Top Sells

1 +$97.6M
2 +$76.6M
3 +$62.4M
4
SWTX
SpringWorks Therapeutics
SWTX
+$41.9M
5
XTNT icon
Xtant Medical Holdings
XTNT
+$34.4M

Sector Composition

1 Healthcare 99.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMA
76
ImageneBio Inc
IMA
$91.3M
$4.74M 0.12%
294,947
RPTX icon
77
Repare Therapeutics
RPTX
$72.6M
$4.62M 0.12%
3,322,488
IMTX icon
78
Immatics
IMTX
$1.24B
$3.87M 0.1%
719,901
-2,367,561
BIOA
79
BioAge Labs
BIOA
$277M
$3.81M 0.1%
921,959
QTTB icon
80
Q32 Bio
QTTB
$26.3M
$3.36M 0.08%
2,252,987
ENGN icon
81
enGene Holdings
ENGN
$437M
$2.47M 0.06%
677,977
-213,639
PASG icon
82
Passage Bio
PASG
$27.1M
$2.42M 0.06%
302,765
-48,966
AMLX icon
83
Amylyx Pharmaceuticals
AMLX
$1.39B
$2.01M 0.05%
313,200
-34,800
MURA icon
84
Mural Oncology
MURA
$36.2M
$1.45M 0.04%
+588,800
INSM icon
85
Insmed
INSM
$40.7B
$1.35M 0.03%
13,459
-15,200
KRYS icon
86
Krystal Biotech
KRYS
$5.97B
$1.26M 0.03%
9,200
-14,300
TSBX
87
DELISTED
Turnstone Biologics
TSBX
$1.11M 0.03%
3,099,265
CMMB
88
Chemomab Therapeutics
CMMB
$13.2M
$1.09M 0.03%
235,248
-200,070
TRAW icon
89
Traws Pharma
TRAW
$15.5M
$896K 0.02%
605,531
KZR icon
90
Kezar Life Sciences
KZR
$45.3M
$883K 0.02%
192,700
ANRO icon
91
Alto Neuroscience
ANRO
$351M
$550K 0.01%
250,000
DHAI
92
DELISTED
DIH Holdings US
DHAI
$469K 0.01%
76,600
LYEL icon
93
Lyell Immunopharma
LYEL
$359M
$457K 0.01%
+51,727
KRRO icon
94
Korro Bio
KRRO
$57.2M
$405K 0.01%
32,400
XERS icon
95
Xeris Biopharma Holdings
XERS
$1.2B
$376K 0.01%
80,420
LSB
96
DELISTED
LakeShore Biopharma
LSB
$55.9K ﹤0.01%
54,799
-85,629
AMGN icon
97
Amgen
AMGN
$181B
-44,200
AZN icon
98
AstraZeneca
AZN
$276B
0
CRDF icon
99
Cardiff Oncology
CRDF
$145M
-573,884
FATE icon
100
Fate Therapeutics
FATE
$111M
-1,680,580